glioma
Conditions
Interventions
Gold Standard:Pathological examination (histopathology and molecular pathology)
Index test:AI-assisted diagnostic model
Sponsors
Huashan Hospital affliated to Fudan University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Retrospective Study: (1) There is no limit to the male or female subjects and no age limit; (2) Complete preoperative MRI scans (including but not limited to T1, T2, T2 Flair, T1 enhancement, DWI, etc.) in our hospital. (3) Undergone surgery (including biopsy surgery) in our hospital; And the postoperative pathological diagnosis was glioma (4) Postoperative imaging follow-up examination (including postoperative CT, MR, etc.) in our hospital; 2. Prospective study: (1) There is no limit to the male or female subjects and no age limit; (2) Complete preoperative imaging examinations (including but not limited to T1, T2, T2 Flair, T1 enhancement, DWI, etc.) in our hospital (3) The results of imaging examination were read by two radiologists or neurosurgeons, and the diagnosis was midline glioma. (4) Undergo surgery (including biopsy) in our hospital
Exclusion criteria
Exclusion criteria: 1.Retrospective Study: (1) The quality of imaging images is poor, and the image quality is difficult to correct. 2. Prospective study: (1) Postoperative pathological diagnosis excludes glioma; (2) Patients did not have imaging follow-up in our hospital.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effectiveness of AI assisted diagnosis and treatment model for midline glioma; | — |
Countries
China
Contacts
Public ContactYifan Yuan
Huashan Hospital affliated to Fudan University
Outcome results
None listed